Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1836 News Items found How Checkpoint Inhibitors for Stage 4 Stomach Cancer Worked for Antonio Thursday, July 3, 2025 Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers. Article The Latest Radiation Therapy for Prostate Cancer: What Every Man Should Know Wednesday, July 2, 2025 It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain. HIFU for Prostate Cancer: Fewer Side Effects and No Surgery or Radiation for Some Patients Monday, June 30, 2025 Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation. MSK Research Highlights, June 18, 2025 Wednesday, June 18, 2025 New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes; investigates opportunities for restoring sensitivity to endocrine therapy; and finds acupuncture may help prostate cancer survivors wake up less often at night to urinate. Reducing Cancer Side Effects Through Online Classes in Yoga, Meditation, and More Tuesday, June 17, 2025 An MSK clinical trial found that participating in integrative therapy classes online could benefit cancer patients in active treatment, not only by reducing fatigue, anxiety, and depression but also lowering hospitalization rates. High-Fructose Diet Harms Neurodevelopment and Leads to Anxiety in Mice, MSK Study Finds Wednesday, June 11, 2025 A new laboratory study from MSK is shedding light on the mechanisms by which high fructose consumption early in life may directly impact brain development and increase the risk of anxiety disorders later on. Introducing DeepHeme, A New AI Tool To Improve Blood Cancer Diagnosis Wednesday, June 11, 2025 Learn more about DeepHeme, an artificial intelligence tool that helps doctors to diagnose blood and bone marrow cancers. 2024 MSK Giving Friday, June 6, 2025 In 2024, the MSK Giving community raised $511 million to advance MSK’s mission of ending cancer for life — every single dollar donated is making a real difference in the way we treat and understand cancer. A Love Story and a Legacy at MSK Friday, June 6, 2025 Tom Scalera and Brett Ravage found a second chance at love through the MSK community after losing their spouses to cancer in 2019. Together, they have raised more than $10 million for cancer research. A Message From the Chairman and President Friday, June 6, 2025 Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment